A collaborative study to establish the 5th International Standard for Unfractionated Heparin.
Twenty-four laboratories participated in a collaborative study to calibrate a replacement for the 4th International Standard for Unfractionated Heparin (82/502). Both candidate materials A and B, gave excellent intra- and inter-laboratory variations (majority of mean %gcv <10%) when assayed against the 4th International Standard. No major differences of potency estimates were found between methods, although the USP method generally gave lower potencies than the other methods and candidate B gave a greater variation between methods than A. Overall, this study showed that the differences between the candidates are marginal. Based on its narrower molecular weight profile, higher specific activity and slightly lower inter-method variation, candidate A, 97/578, was proposed and accepted in October, 1998, by the Expert Committee on Biological Standardisation of the World Health Organisation to be the 5th International Standard for Unfractionated Heparin with an assigned potency of 2031 IU/ampoule.
Gray
E
E
National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, UK. egray@nibsc.ac.uk
Walker
A D
AD
Mulloy
B
B
Barrowcliffe
T W
TW
D001780:Blood Coagulation Tests; D002138:Calibration; D004355:Drug Stability; D006493:Heparin / Q000592:standards*; D006801:Humans; D007391:International Cooperation; D015588:Observer Variation; D012015:Reference Standards; D015203:Reproducibility of Results; D014944:World Health Organization
D006493:Heparin